VIVUS (VVUS) Resumes Trading +17%

July 18, 2012 7:15 AM EDT
Share of VIVUS Inc. (Nasdaq: VVUS) resume trading up 17% after the FDA approved obesity drug Qsymia.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

FDA, Momentum Movers, Trader Talk, Trading Halts

Add Your Comment